Rapid Dose Therapeutics Announces Nutraceutical Reseller Agreement for Canada, United States and India BURLINGTON, Ontario, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce an Agreement with Perennial Brands, a DCM...

Rapid Dose Therapeutics Receives Funding for Scale-Up Manufacturing and Commercialization of Quickstrip™ Product BURLINGTON, Ontario, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) (“RDT” or the “Corporation”) is pleased to announce the company has...

Rapid Dose Therapeutics and McMaster University Awarded NSERC Research and Development Grant to Develop Oral Dissolvable Film for Enhanced Drug Delivery BURLINGTON, Ontario, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce their newest research partnership program...